Quality of Life Assessment Using Dermatology Life Quality Index Questionnaire in Patients With Alopecia Attending a Tertiary Care Teaching Hospital: A Prospective Observational Study

This study assessed the quality of life (QoL) in 65 adults with alopecia using the Dermatology Life Quality Index (DLQI) at a tertiary care teaching hospital in Navi Mumbai, India. The majority of participants were aged 21–40 years, female, and urban residents. Androgenetic alopecia was the most common subtype (69.2%), followed by telogen effluvium (16.9%). The DLQI results showed that 12.3% of patients experienced no effect, 36.9% had a minimal effect, 41.5% had a moderate effect, and 9.2% had a very large effect on their QoL. Minoxidil was prescribed to 72.3% of patients, with topical formulations being the most common. The study concluded that most adults with alopecia experienced measurable QoL impairment, primarily within minimal-to-moderate ranges, with minoxidil as the main treatment.